Tech Company Financing Transactions
Gemmus Pharma Funding Round
Gemmus Pharma closed a $3.3 million Series B funding round on 5/13/2014. Investors included BlueTree Allied Angels, Life Science Angels and Tech Coast Angels.
Transaction Overview
Company Name
Announced On
5/13/2014
Transaction Type
Venture Equity
Amount
$3,300,000
Round
Series B
Investors
Proceeds Purpose
The company intends to use the funds to complete production and toxicology studies for an IND filing by the end of the year.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
409 Illinois Ave.
San Francisco, CA 94158
USA
San Francisco, CA 94158
USA
Phone
Website
Email Address
Overview
Gemmus develops innovative pharmaceutical products for the treatment of influenza and other viral infectious diseases.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Daryl Faulds
Chief Financial Officer
Jonathan Ross
President
William Guilford
VP - Finance
William Holstein
Browse more venture capital transactions:
Prev: 5/13/2014: LearnSprout venture capital transaction
Next: 5/13/2014: SIGNiX venture capital transaction
Share this article
Where The Data Comes From
We report on every notable VC transaction. VC transactions reported here are sourced from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs